Home / Community / News / News

News

06/02/2017 - 4:29pm

A recent review article makes the case that DM is a brain disease and that better understanding of and treatment strategies for the neurological consequences of DM are essential.

06/02/2017 - 3:53pm

MDF staff recently attended the 2017 annual meeting of the American Academy of Neurology, in Boston, MA. Here are highlights from that meeting.

05/15/2017 - 2:54pm

MDF is also happy to help you understand whether something is in a legitimate clinical trial, an approved therapy…or not.

03/13/2017 - 11:30am

A potentially revolutionary technology may allow development of a drug for DM that can correct a patient’s DNA by selectively removing the expanded CTG and CCTG repeats in DM1 and DM2, respectively.

02/24/2017 - 9:50am

Gene editing is a potential avenue for therapy development in DM. With the safety, efficacy and delivery challenges, how do we get there?

Partners

© Myotonic Dystrophy Foundation. All rights reserved.